The National Institutes of Health supports small pilot projects to advance human virome tools, expand sampling, and study virus-host interactions; clinical trials are not allowed.
Funder: National Institutes of Health
Due Dates: November 10, 2026 (New applications) | October 22, 2027 (New applications)
Funding Amounts: $50,000–$100,000 award range; direct costs capped at $100,000 annually for up to 2 years; $2 million estimated total funding
Summary: Supports small pilot projects that expand human virome research, improve research tools, and define interactions between the virome and host.
Key Information: Clinical trials are not allowed, and projects must complement rather than duplicate existing Human Virome Program work.
The NIH Common Fund Human Virome Program (HVP) supports pilot projects to expand understanding of the “healthy” human virome: viruses normally present in the human body without evidence of disease. The program seeks tools, models, and methods for studying virome composition, variation, relationships with host factors, and effects on health. This R03 opportunity is administered by the National Institute of Dental and Craniofacial Research (NIDCR).
Supported work includes validating or improving HVP tools using cohort specimens or animal samples, expanding cohorts or biospecimen sampling sites, developing assays and computational methods, and investigating virome–microbiota–host interactions. Both viruses infecting human cells and those infecting human-associated microbes are relevant. Pilot projects should expand and complement the HVP consortium, with collaboration across the program expected. Researchers outside the current HVP are encouraged to apply.